
    
      Subjects enrolled on the BP-004 study who have completed or discontinued from the study, and
      are beyond Day 180 will be requested to enroll on this long-term follow up protocol. Long
      term follow up for gene therapy clinical and safety endpoints will continue up to 15 years.
    
  